Do you want to read an article? Please log in or register.
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCT
Hypertension
Related content
Further Publications
Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial
Lancet
Minnen OV, Lansink-Hartgring AO, van Amstel RBE, van den Bogaard B, Bunge JJH, Delnoij TSR, Droogh JM, Koppenhagen LV, Kraemer CVE, Kuijpers M, Maas JJ, Metz J, van de Poll MCG, Raasveld SJ, Dos Reis Miranda D, Vart P, Vermeulen KM, Vlaar APJ, van den Bergh WM, Dutch ECLS Study Group
doi: 10.1016/S0140-6736(26)00851-2
Further Publications
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
Circulation
Johansen ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sánchez C, Loiacono MM, Harris RC, Dufournet M, van Aalst R, Chit A, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Duran-Parrondo C, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, Mirás-Carballal S, González-Pérez JM, Solomon SD, Sivapalan P, Martel CJ, Jensen JUS, Martinón-Torres F, Biering-Sørensen T, DANFLU-2 Study Group and the GALFLU Trial Team
doi: 10.1161/CIRCULATIONAHA.125.077801
Cardiovascular Risk and DiseasesFurther Publications
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial
JAMA Cardiol
Johansen ND, Modin D, Loiacono MM, Harris RC, Dufournet M, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Bartholdy KV, Bernholm KF, Borchsenius JIH, Davidovski FS, Davodian LW, Dons M, Duus LS, Espersen C, Fussing FH, Jensen AMR, Landler NE, Langhoff ACF, Lassen MCH, Nielsen AB, Ottosen CI, Sengeløv M, Skaarup KG, Pareek M, Solomon SD, Landray MJ, Gislason GH, Køber L, Sivapalan P, Martel CJ, Jensen JUS, Biering-Sørensen T
doi: 10.1001/jamacardio.2025.3460
Hypertension
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
Lancet
Azizi M, Brown JM, Dwyer JP, Flack JM, Jones ESW, Kurlyandskaya R, Li H, Birve F, Lihn AS, Perl S, Schlaich MP, Shibata H, Wang JG, Williams B, Bax24 investigators
doi: 10.1016/S0140-6736(25)02549-8
Hypertension
Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
J Am Coll Cardiol
Laffin LJ, Wang Q, Sarraju A, Touyz RM, Schlaich MP, Cohen DL, Mahfoud F, Mitchell LM, Mitchell J, Wolski K, Dennis P, Akere A, Li W, Chen G, Cohen YZ, Kim J, Cooper CG, Ramesan P, Edelberg JM, Nissen SE, KARDINAL Investigators
doi: 10.1016/j.jacc.2026.03.034
Myocardial InfarctionFurther Publications
Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial
JAMA Cardiol
Puymirat E, Soulat G, Lattuca B, Bouleti C, Delarche N, Roubille F, Cottin Y, Bression D, Combaret N, Gerbaud E, Lhermusier T, Biere L, Dubreuil O, Mousseaux E, Steg PG, Cayla G, Lemesle G, Silvain J, Dillinger JG, Georges JL, Ducrocq G, Genet T, Morelle JF, Montalescot G, Berard L, Rousseau A, Soen M, Simon T, Danchin N, APERITIF study investigators
doi: 10.1001/jamacardio.2026.0026
Atrial Fibrillation
Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III
J Am Heart Assoc
Corica B, Romiti GF, Proietti M, Mei DA, Boriani G, Olshansky B, Huisman MV, Lip GYH, GLORIA‐AF Investigators
doi: 10.1161/JAHA.125.044293
Cardiovascular Risk and Diseases
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III
Cardiovasc Diabetol
Romiti GF, Mei DA, Corica B, Proietti M, Boriani G, Olshansky B, Chao TF, Huisman MV, Lip GYH, GLORIA-AF Investigators
doi: 10.1186/s12933-025-02950-y
RECOMMENDED
Hypertension
Blood Pressure 15 to 90 Days After a Hypertensive Disorder of Pregnancy and Later Hypertension
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension
Urrutia RP, Loop MS, Johnson JD, Wang TY, Price TM, Daubert MA
doi: 10.1161/HYPERTENSIONAHA.124.24393